Table I.
Mutagenicity of EOM of Oil-Burn Emissions
Dose | Rev/platea | |||||||
---|---|---|---|---|---|---|---|---|
(µg EOM/ | −S9 | +S9 | ||||||
Strain | plate) | Exp 1 | Exp 2 | Exp 3 | Exp 1 | Exp 2 | Exp 3 | |
TA100 | 0 | 127 | 121 | 130 | 120 | |||
1 | 108 | 130 | ||||||
5 | 112 | 158 | ||||||
10 | 168 | 149 | 258 | 269 | ||||
25 | 195 | 175 | 383 | 416 | ||||
50 | 229 | 182 | 599 | 529 | ||||
100 | 245 | 264 | 809b | 707b | ||||
NaN3 | 722 | 732 | ||||||
2AA | 871 | 895 | ||||||
Blank | 129 | 109 | ||||||
YG1041 | 0 | 87 | 89 | 81 | 106 | |||
1 | 77 | 70 | ||||||
5 | 104 | 107 | ||||||
10 | 142 | 168 | 147 | 170 | ||||
25 | 202 | 265 | 200 | 248 | ||||
50 | 380 | 391 | 346 | 377 | ||||
100 | 535 | 616 | 643 | 633 | ||||
2NF | 1648 | 1547 | ||||||
2AA | 1237 | 1786 | ||||||
Blank | 100 | 118 | ||||||
TA98 | 0 | 43 | 56 | 49 | 64 | |||
10 | 44 | 60 | 86 | 92 | ||||
25 | 70 | 82 | 99 | 102 | ||||
50 | 106 | 95 | 161 | 152 | ||||
100 | 115b | 119b | 256 | 250 | ||||
2NF | 372 | 305 | ||||||
2AA | 297 | 594 | ||||||
Blank | 38 | 45 | 59 | 75 | ||||
TA104 | 0 | 225 | 210 | 199 | 296 | 273 | 279 | |
10 | 243 | 383 | ||||||
25 | 278 | 268 | 240 | 453 | 494 | 513 | ||
50 | 295 | 292 | 287 | 535 | 602 | 568 | ||
100 | 322 | 348 | 345 | 588b | 635b | 716b | ||
252.5 | 458 | 454 | 906b | 856b | ||||
MG | 1338 | 1563 | 1153 | |||||
2AA | 497 | 655 | 565 | |||||
Blank | 221 | 253 | 285 | 326 | ||||
YG1024 | 0 | 30 | 33 | 46 | 48 | |||
10 | 99 | 50 | 108 | 94 | ||||
25 | 120 | 90 | 222 | 128 | ||||
50 | 177 | 132 | 345 | 215 | ||||
100 | 199b | 181b | 360b | 323b | ||||
2NF | 2116 | 2065 | ||||||
2AA | 1769 | 2226 | ||||||
Blank | 23 | 33 | 48 | 40 | ||||
YG1042 | 0 | 108 | 108 | 112 | 123 | |||
10 | 138 | 133 | 253 | 215 | ||||
25 | 188 | 155 | 362 | 312 | ||||
50 | 167 | 181 | 554 | 414 | ||||
100 | 232 | 191 | 711b | 599b | ||||
NaN3 | 977 | 956 | ||||||
2AA | 621 | 830 | ||||||
Blank | 115 | 109 | 123 | 115 |
Data for DMSO (0) controls and the positive controls are the average ± SE of 3 plates each per experiment for a total of 6 plates. Data for the method blanks are for 100 µl/plate and are the average of 2 plates (1 each from 2 independent experiments) except for TA100 and YG1041, which are based on 1 plate from only 1 experiment. Data for the EOM are single plates/dose for each experiment. The positive control data for each experiment represent the average of 3 plates. The positive controls were 2-nitrofluorene (2NF) at 3 µg/plate, 2-aminoanthracene (2AA) at 0.5 µg/plate, sodium azide (NaN3) at 3 µg/plate, and methylglyoxal (MG) at 200 µg/plate. The mean ± SE rev/plate of the DMSO controls for all experiments combined for −/+ S9 were 124 ± 3/125 ± 5 for TA100, 88 ± 1/94 ± 13 for YG1041, 50 ± 7/57 ± 8 for TA98, 211 ± 8/283 ± 7 for TA104, 32 ± 2/47 ± 1 for YG1024, and 108 ± 0/118 ± 6 for YG1042. The mean ± SE rev/plate of the method blanks for all experiments combined for −/+ S9 were 129/109 for TA100, 100/118 for YG1041, 42 ± 4/67 ± 8 for TA98, 237 ± 16/306 ± 21 for TA104, 28 ± 5/44 ± 4 for YG1024, and 112 ± 3/119 ± 4 for YG1042. The mean ± SE rev/plate for the positive controls for all experiments combined for −/+ S9 were 727 ± 5 NaN3/883 ± 12 2AA for TA100, 1598 ± 51 2NF/1512 ± 275 2AA for YG1041, 339 ± 34 2NF/446 ± 149 2AA for TA98, 1155 ± 302 MG/768 ± 198 2AA for TA104, 2091 ± 26 2NF/1998 ± 229 2AA for YG1024, and 967 ± 11 NaN3/726 ± 105 2AA for YG1042.
These data were not used in the linear regressions because they were outside of the linear portion of the dose-response curves.